Hepatitis C is a liver disease caused by the Hepatitis C virus (HCV). The infections can cause inflammation and liver failure.
A recent analysis reveals that patients infected with Hepatitis C virus (HCV) can be treated by using more effective and tolerable medications.
In an analysis of all HCV antiviral treatment regimens (N=107,079) initiated from 1999 through 2015 in the US Veterans Affairs national healthcare system, cure rates increased steadily from 19.2% in 1999 to 36.0% in 2010 before a remarkable increase to 90.5% in 2015. The number of patients achieving sustained virologic response was 1313 in 2010, the last year of the interferon era and increased 5.6-fold to 7377 in 2014 and 21-fold to 28,084 in 2015.